Psychopharmacology and Psychiatry Updates
A podcast by Psychopharmacology Institute
Categorie:
213 Episodio
-
Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction
Pubblicato: 25/6/2024 -
Insomnia and Depression: A Tangled Web
Pubblicato: 20/6/2024 -
ADHD Treatment During Pregnancy: Insights from Denmark
Pubblicato: 15/6/2024 -
The Power of Nonpharmacologic Therapies in Fibromyalgia
Pubblicato: 10/6/2024 -
Highlights From APA 2024: Key Insights on Psychopharmacology
Pubblicato: 5/6/2024 -
Antidepressants in Pregnancy: Weighing the Evidence
Pubblicato: 31/5/2024 -
Unraveling the Pharmacological Puzzle of Fibromyalgia
Pubblicato: 26/5/2024 -
Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa
Pubblicato: 21/5/2024 -
Beyond the Pain: Diagnosing Fibromyalgia
Pubblicato: 17/5/2024 -
Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects
Pubblicato: 11/5/2024 -
Mastering Clozapine: Adverse Effect Management
Pubblicato: 6/5/2024 -
Preventing Depression and Anxiety Relapse in Youth
Pubblicato: 1/5/2024 -
Charting the Clozapine Course: Titration and Monitoring
Pubblicato: 26/4/2024 -
Smoking and Psychosis: Insights from the PATH Study
Pubblicato: 21/4/2024 -
Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia
Pubblicato: 16/4/2024 -
Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry
Pubblicato: 11/4/2024 -
Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice
Pubblicato: 6/4/2024 -
Zuranolone: A New Dawn for Postpartum Depression Treatment
Pubblicato: 1/4/2024 -
Micronutrients for Psychiatric Disorders: Optimizing Clinical Use
Pubblicato: 27/3/2024 -
Olanzapine in Pregnancy: Examining the Risks
Pubblicato: 22/3/2024
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.